Athersys Inc. (Nasdaq: ATHX), a biopharmaceutical company focused on developing an innovative stem cell platform, similar to companies like Mesoblast (MSB: ASX), Osiris (Nasdaq: OSIR) and ThermoGenesis Corp (Nasdaq: KOOL), recently announced that its CEO would deliver the keynote address at the World Stem Cell Summit 2011.
Recent Posts
- The Download: what’s next for AI, and stem-cell therapies
- 10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs
- A pilot raced through the airport to surprise an old friend: the woman who saved his life
- 8 Trends to Watch in the Cell and Gene Therapy Market
- UNL researchers delving into which foods help slow aging of brain
- Australia’s Fast New 3D Bioprinter Can Mimic Human Tissues